AEON Biopharma, Inc. (AEON)

AEON Biopharma was planning to go public, but the IPO has been withdrawn.
Stock Price: $14.00 - $16.00
Current IPO price range

Income Statement (Annual)

Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Year 20202019
Revenue
2.523.36
Revenue Growth (YoY)
-24.99%-
Cost of Revenue
-0
Gross Profit
2.523.36
Selling, General & Admin
11.5946.04
Research & Development
7.324.81
Other Operating Expenses
06.47
Operating Expenses
18.9157.32
Operating Income
-16.39-53.97
Interest Expense / Income
04.46
Other Expense / Income
16.52-204.09
Pretax Income
-32.91145.67
Income Tax
--14.65
Net Income
-32.91160.32
Net Income Common
-32.91172.92
Gross Margin
100.00%99.97%
Operating Margin
-650.83%-1607.57%
Profit Margin
-1307.11%5151.03%
Free Cash Flow Margin
-375.74%-1382.75%
Effective Tax Rate
0.00%-10.05%
EBITDA
-32.91151.62
EBITDA Margin
-1307.07%4516.59%
Depreciation & Amortization
-1.5
EBIT
-32.91150.13
EBIT Margin
-1307.07%4472.06%
Source: IPO financials are sourced from S-1 and S-1/A filings submitted to the Securities and Exchange Commission (SEC).